Status:
COMPLETED
An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Obesity and Obesity-related Medical Conditions
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
A study to determine the safety and efficacy of an investigational drug in patients with obesity.
Eligibility Criteria
Inclusion
- Obese patients with a body mass index between 30kg/m2 and 43 kg/m2, inclusive (BMI between 27 kg/m2 and 43kg/m2, inclusive for those with obesity-related comorbidities including hypertension, dyslipidemia and sleep apnea).
Exclusion
- Patients with serious or unstable current or past medical conditions.
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2007
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00131430
Start Date
August 1 2005
End Date
May 1 2007
Last Update
June 7 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.